SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News
ADCendo
ADCendo
Company

Last deal

$17.36M
Local Amount - EUR 16M

Amount

Series A

Stage

29.05.2024

Date

3

all rounds

$114.47M

Total amount

date founded

Financing round

General

About Company
ADCendo ApS develops targeted anti-cancer therapies using antibody-drug conjugates.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

founders

Number of employees

1-10

Company Type

For Profit

Last funding type

Series A

IPO status

Private

Description

Founded in 2017 in Copenhagen, ADCendo ApS is a biotech company that focuses on developing new types of anti-cancer drugs. They specialize in antibody-drug conjugates (ADCs) that target specific cancer forms with a significant unmet need for treatment. ADCendo aims to create novel medicines for cancer patients by leveraging their expertise in ADC technology. The company originated as a spin-out from The Finsen Laboratory of Rigshospitalet and the University of Copenhagen.
Contacts

location

Copenhagen, Denmark

Contact Email

Website URL

http://adcendo.dk/

Social url

Similar Companies
1000
Kenjockety Biotechnology
Kenjockety BiotechnologyKenjockety Biotechnology develops bispecific antibodies to combat drug-resistant cancers.
Kenjockety Biotechnology

Kenjockety Biotechnology

Kenjockety Biotechnology develops bispecific antibodies to combat drug-resistant cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

San Francisco, CA, USA
Inspirna, Inc.(formerly Rgenix, Inc.)
Inspirna, Inc.(formerly Rgenix, Inc.)Inspirna is a biotechnology company that develops drugs to treat cancer.
Inspirna, Inc.(formerly Rgenix, Inc.)

Inspirna, Inc.(formerly Rgenix, Inc.)

Inspirna is a biotechnology company that develops drugs to treat cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

New York, NY, USA

total rounds

6

total raised

$139.5M
BeiGene
BeiGeneBeiGene is a biotech company focused on developing innovative cancer drugs.
BeiGene

BeiGene

BeiGene is a biotech company focused on developing innovative cancer drugs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Changping District, Beijing, China

total rounds

7

total raised

$6.79B

count Of Investments

3
BiSiChem
BiSiChemBiSiChem is a biotech company focused on drug discovery and development.
BiSiChem

BiSiChem

BiSiChem is a biotech company focused on drug discovery and development.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Bundang-dong, Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea

total rounds

2

total raised

$8.81M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$114.47M

Money Raised

Their latest funding was raised on 29.05.2024. Their latest investor Dawn Biopharma. Their latest round Series A

Date 
Funding Round 
Investors 
Money Raised 
Lead 
29.05.2024
Series A
7
$17.36M
Local Amount - EUR 16M
Dawn Biopharma
04.04.2023
Series A
6
$33.78M
Local Amount - EUR 31M
Pontifax
Pontifax
29.04.2021
Series A
5
$61.84M
Local Amount - EUR 51M
Novo Holdings
Novo Holdings
Ysios Capital
Ysios Capital

Dawn Biopharma

Dawn Biopharma is a global investment firm of KKR.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Consulting

count Of Investments

4
Pontifax

Pontifax

Pontifax is a healthcare-dedicated venture capital firm that finances pharmaceutical and life sciences companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

Herzliya, Israel

count Of Investments

97

count Of Exists

9
Novo Holdings

Novo Holdings

Novo Holdings is a life science investor focused on growing investment assets for scientific, social, and humanitarian purposes.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

2900 Hellerup, Denmark

count Of Investments

297

count Of Exists

43
Ysios Capital

Ysios Capital

Ysios Capital provides venture capital funding to Spanish life science companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Biotechnology

Location

Donostia-San Sebastian, Gipuzkoa, Spain

count Of Investments

63

count Of Exists

9
Co-Investors
Investors
8
2

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Dawn Biopharma
Yes
Series A
Iyona Rajkomar
Iyona Rajkomar
RA Capital Management
RA Capital Management
No
Series A
—
HealthCap
HealthCap
No
Series A
—

Dawn Biopharma

Dawn Biopharma is a global investment firm of KKR.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Consulting

count Of Investments

4
Iyona Rajkomar

Iyona Rajkomar

Iyona Rajkomar is a Partner at Pontifax VC.

RA Capital Management

RA Capital Management

RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Financial Services

Location

Boston, MA, USA

count Of Investments

373

count Of Exists

33
HealthCap

HealthCap

HealthCap is a venture capital firm that invests in life sciences globally.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Venture Capital

Location

Stockholm, Sweden

count Of Investments

96

count Of Exists

14

People

Founders
4
Christoffer Nielsen
Christoffer Nielsen

Christoffer Nielsen

Christoffer Nielsen is a Co-founder & COO at ADCendo.

current job

ADCendo
ADCendo

organization founded

1
Christoffer Nielsen

Christoffer Nielsen

Lars H. Engelholm
Lars H. Engelholm

Lars H. Engelholm

Lars H. Engelholm is a Co-founder at ADCendo.

current job

ADCendo
ADCendo

organization founded

1
Lars H. Engelholm

Lars H. Engelholm

Niels Behrendt
Niels Behrendt

Niels Behrendt

Niels Behrendt is a Doctor of Science and Ph.D. from the University of Copenhagen. He has been active in cancer research for more than 20 years and has particular expertise in the structure, function, and targeting of receptors engaged in cancer invasion. He has longstanding experience in research leadership and has supervised a major part of the scientific work that enables the cancer-targeting strategy of ADCendo.

current job

ADCendo
ADCendo

organization founded

1
Niels Behrendt

Niels Behrendt

Henrik Stage
Henrik Stage

Henrik Stage

Henrik Stage is the Founder at Adcendo. He attended Copenhagen Business School.

current job

ADCendo
ADCendo
Henrik Stage

Henrik Stage

Employee Profiles
5
Dominik Mumberg
Dominik Mumberg

Dominik Mumberg

Chief Scientific Officer

Chief Scientific Officer

Henrik Stage
Henrik Stage

Henrik Stage

Co-founder & CEO

Co-founder & CEO

Niels Behrendt
Niels Behrendt

Niels Behrendt

Co-founder

Co-founder

Lars H. Engelholm
Lars H. Engelholm

Lars H. Engelholm

Co-founder

Co-founder

Christoffer Nielsen
Christoffer Nielsen

Christoffer Nielsen

Co-founder & COO

Co-founder & COO

Activity

Recent News
1
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

week